Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous

Fardis Vosoughi1, Diako Seyedi2, Parnian Rahnama2

  • 1Department of Orthopaedics and Trauma Surgery, Shariati Hospital, Tehran University Of Medical Sciences, Tehran, Iran.

The Knee
|April 26, 2026
PubMed
Abstract

Insights

Intraosseous (IO) vancomycin prophylaxis in total knee arthroplasty (TKA) significantly lowers periprosthetic joint infection (PJI) and wound complication rates. This method achieves higher local antibiotic levels without increasing risks of kidney injury, blood clots, or revision surgery.

Area of Science:

  • Orthopedic Surgery
  • Infectious Disease
  • Pharmacology

Background:

  • Periprosthetic joint infection (PJI) is a significant complication following total joint arthroplasty (TJA).
  • Concerns regarding antimicrobial resistance to intravenous (IV) vancomycin have prompted investigation into alternative prophylaxis methods.
  • Intraosseous (IO) vancomycin is being explored as a potentially more effective prophylactic agent in TJA.

Purpose of the Study:

  • To compare the efficacy and safety of intraosseous (IO) vancomycin versus intravenous (IV) prophylaxis in total joint arthroplasty (TJA).
  • To evaluate outcomes including periprosthetic joint infection (PJI), organism-specific infections, wound complications, revision rates, pharmacokinetics, acute kidney injury (AKI), and deep vein thrombosis (DVT).

Main Methods:

  • A systematic review and meta-analysis of clinical studies involving adults undergoing total knee arthroplasty (TKA) or total hip arthroplasty (THA).
  • Studies compared IO vancomycin with alternative IV prophylaxis methods.
  • Outcomes were analyzed using random-effects models and stratified by follow-up intervals (30 days, 90 days, 1 year).

Main Results:

  • Intraosseous vancomycin resulted in significantly higher vancomycin concentrations in bone and fat tissue compared to IV administration.
  • IO vancomycin significantly reduced overall PJI and Gram-positive infections in primary TKA cases.
  • Non-operative wound complications were significantly lower with IO vancomycin, while rates of reoperation-requiring complications, AKI, DVT, and revision were comparable between groups.

Conclusions:

  • Intraosseous vancomycin prophylaxis demonstrates superior local antibiotic concentrations compared to IV administration.
  • IO vancomycin significantly reduces the incidence of PJI and superficial wound complications in primary TKA.
  • This method does not elevate the risk of renal complications, thrombotic events, or revision surgery.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
258
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
2.2K
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
331